Literature DB >> 20639488

TLR3 and Rig-like receptor on myeloid dendritic cells and Rig-like receptor on human NK cells are both mandatory for production of IFN-gamma in response to double-stranded RNA.

Ivan Perrot1, Florence Deauvieau, Catherine Massacrier, Nicola Hughes, Pierre Garrone, Isabelle Durand, Olivier Demaria, Nicolas Viaud, Laurent Gauthier, Mathieu Blery, Nathalie Bonnefoy-Berard, Yannis Morel, Jurg Tschopp, Lena Alexopoulou, Giorgio Trinchieri, Carine Paturel, Christophe Caux.   

Abstract

Cross-talk between NK cells and dendritic cells (DCs) is critical for the potent therapeutic response to dsRNA, but the receptors involved remained controversial. We show in this paper that two dsRNAs, polyadenylic-polyuridylic acid and polyinosinic-polycytidylic acid [poly(I:C)], similarly engaged human TLR3, whereas only poly(I:C) triggered human RIG-I and MDA5. Both dsRNA enhanced NK cell activation within PBMCs but only poly(I:C) induced IFN-gamma. Although myeloid DCs (mDCs) were required for NK cell activation, induction of cytolytic potential and IFN-gamma production did not require contact with mDCs but was dependent on type I IFN and IL-12, respectively. Poly(I:C) but not polyadenylic-polyuridylic acid synergized with mDC-derived IL-12 for IFN-gamma production by acting directly on NK cells. Finally, the requirement of both TLR3 and Rig-like receptor (RLR) on mDCs and RLRs but not TLR3 on NK cells for IFN-gamma production was demonstrated using TLR3- and Cardif-deficient mice and human RIG-I-specific activator. Thus, we report the requirement of cotriggering TLR3 and RLR on mDCs and RLRs on NK cells for a pathogen product to induce potent innate cell activation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20639488      PMCID: PMC3545654          DOI: 10.4049/jimmunol.1000532

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

Review 1.  Toll-like receptor signalling.

Authors:  Shizuo Akira; Kiyoshi Takeda
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

2.  Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo.

Authors:  N C Fernandez; A Lozier; C Flament; P Ricciardi-Castagnoli; D Bellet; M Suter; M Perricaudet; T Tursz; E Maraskovsky; L Zitvogel
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

3.  DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction.

Authors:  Christian Adam; Susan King; Thomas Allgeier; Heidi Braumüller; Carolin Lüking; Josef Mysliwietz; Anja Kriegeskorte; Dirk H Busch; Martin Röcken; Ralph Mocikat
Journal:  Blood       Date:  2005-03-15       Impact factor: 22.113

4.  Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2.

Authors:  R Schwandner; R Dziarski; H Wesche; M Rothe; C J Kirschning
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

5.  The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions.

Authors:  Franca Gerosa; Andrea Gobbi; Penelope Zorzi; Stephanie Burg; Francine Briere; Giuseppe Carra; Giorgio Trinchieri
Journal:  J Immunol       Date:  2005-01-15       Impact factor: 5.422

6.  Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming.

Authors:  Alfonso Martín-Fontecha; Lindy L Thomsen; Sara Brett; Craig Gerard; Martin Lipp; Antonio Lanzavecchia; Federica Sallusto
Journal:  Nat Immunol       Date:  2004-11-07       Impact factor: 25.606

7.  Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection.

Authors:  J S Orange; C A Biron
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

8.  An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections.

Authors:  J S Orange; C A Biron
Journal:  J Immunol       Date:  1996-02-01       Impact factor: 5.422

9.  CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells.

Authors:  Simona Sivori; Michela Falco; Mariella Della Chiesa; Simona Carlomagno; Massimo Vitale; Lorenzo Moretta; Alessandro Moretta
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-24       Impact factor: 11.205

Review 10.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

View more
  40 in total

1.  Restoration of TLR3-activated myeloid dendritic cell activity leads to improved natural killer cell function in chronic hepatitis B virus infection.

Authors:  Eric T T L Tjwa; Gertine W van Oord; Paula J Biesta; Andre Boonstra; Harry L A Janssen; Andrea M Woltman
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

2.  Innate immune agonist, dsRNA, induces apoptosis in ovarian cancer cells and enhances the potency of cytotoxic chemotherapeutics.

Authors:  Danielle N Van; Charlotte F Roberts; James D Marion; Sandrine Lépine; Kuzhuvelil B Harikumar; Jessica Schreiter; Catherine I Dumur; Xianjun Fang; Sarah Spiegel; Jessica K Bell
Journal:  FASEB J       Date:  2012-04-24       Impact factor: 5.191

Review 3.  Clinical view on the importance of dendritic cells in asthma.

Authors:  Rohit Gaurav; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2013-10       Impact factor: 4.473

Review 4.  TLR3 immunity to infection in mice and humans.

Authors:  Shen-Ying Zhang; Melina Herman; Michael J Ciancanelli; Rebeca Pérez de Diego; Vanessa Sancho-Shimizu; Laurent Abel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2013-01-03       Impact factor: 7.486

5.  A quantitative proteomic approach for detecting protein profiles of activated human myeloid dendritic cells.

Authors:  Daniela M Schlatzer; Julia Sugalski; Jean-Eudes Dazard; Mark R Chance; Donald D Anthony
Journal:  J Immunol Methods       Date:  2011-09-16       Impact factor: 2.303

Review 6.  Immune responses triggering colitis and colitis-associated carcinoma.

Authors:  Rebecca Kesselring; Stefan Fichtner-Feigl
Journal:  Langenbecks Arch Surg       Date:  2012-03-01       Impact factor: 3.445

7.  SIDT2 Transports Extracellular dsRNA into the Cytoplasm for Innate Immune Recognition.

Authors:  Tan A Nguyen; Blake R C Smith; Michelle D Tate; Gabrielle T Belz; Marilou H Barrios; Kirstin D Elgass; Alexandra S Weisman; Paul J Baker; Simon P Preston; Lachlan Whitehead; Alexandra Garnham; Rachel J Lundie; Gordon K Smyth; Marc Pellegrini; Meredith O'Keeffe; Ian P Wicks; Seth L Masters; Craig P Hunter; Ken C Pang
Journal:  Immunity       Date:  2017-09-12       Impact factor: 31.745

8.  Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs.

Authors:  Joseph R Francica; Daniel E Zak; Caitlyn Linde; Emilio Siena; Carrie Johnson; Michal Juraska; Nicole L Yates; Bronwyn Gunn; Ennio De Gregorio; Barbara J Flynn; Nicholas M Valiante; Padma Malyala; Susan W Barnett; Pampi Sarkar; Manmohan Singh; Siddhartha Jain; Margaret Ackerman; Munir Alam; Guido Ferrari; Andres Salazar; Georgia D Tomaras; Derek T O'Hagan; Alan Aderem; Galit Alter; Robert A Seder
Journal:  Blood Adv       Date:  2017-11-17

9.  Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma.

Authors:  Diwakar Davar; Hong Wang; Joe-Marc Chauvin; Ornella Pagliano; Julien J Fourcade; Mignane Ka; Carmine Menna; Amy Rose; Cindy Sander; Amir A Borhani; Arivarasan Karunamurthy; Ahmad A Tarhini; Hussein A Tawbi; Qing Zhao; Blanca H Moreno; Scott Ebbinghaus; Nageatte Ibrahim; John M Kirkwood; Hassane M Zarour
Journal:  J Clin Oncol       Date:  2018-10-25       Impact factor: 44.544

10.  Signaling network of dendritic cells in response to pathogens: a community-input supported knowledgebase.

Authors:  Sonali Patil; Hanna Pincas; Jeremy Seto; German Nudelman; Irina Nudelman; Stuart C Sealfon
Journal:  BMC Syst Biol       Date:  2010-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.